Prepare to Level Up at the SLAS2020 International Conference and Exhibition, January 25-29, 2020.
Save the Date for five days of innovation, connection, technology, research and discovery.
SLAS2020 Program Chairs are Melanie Leveridge, GlaxoSmithKline (UK) and Andrew Napper, Ph.D., Evotec (USA).
SLAS2020.ORG > #SLAS2020
Board Director, BenevolentAI
Dr. Hunter has more than 30 years of experience in the bioscience research sector, working across academia and industry including leading neurology and gastrointestinal drug discovery and early clinical development for GlaxoSmithKline. She now leads BenevolentAI, which uses AI to augment the research capabilities of drug scientists, radically changing the way R&D is done -- from target identification and validation, through medicinal chemistry and lead optimization to clinical PoC.
Professor, University of Glasgow
With one of the largest multidisciplinary chemistry-based research teams in the world, Dr. Cronin’s group at the University of Glasgow is developing the concept of ‘Chemputing’ which enables the universal digitization of chemistry, in order to create artificial life forms, find alien life, further explore the digitization of chemistry, understand how information can be encoded into chemicals and construct chemical computers.
The Call for Abstracts will open in May 2019.
Plan ahead to submit your podium or poster abstract for presentation in San Diego. Opportunities will be available for the Tony B. Academic Travel Award, Academic Collaboration Presentations, SLAS Innovation Award, Student Poster Awards and more. Bookmark this website for details as they become available!
Consider how your work could fit in to one or more of these 10 educational tracks: